Search

everythinglearnresearchcommunity

for

Search:↓

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Chemotherapy drugs can cause abnormal growth and changes in healthy skin and gland cells.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The skin's immune system helps it regenerate and fight infections.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Understanding hair follicles through various models can help develop new treatments for hair disorders.

Special cell particles from macrophages can help hair grow.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

A new method using fat tissue cells may help treat hair loss.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Nanobioceramics can effectively and cheaply heal wounds without side effects.